MARKETS / NYSE / ICL
NYSE · AGRICULTURAL CHEMICALS · LARGE CAP

ICL Group Ltd. ICL

11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$7.2B
▲ 4.6% vs FY2024
EPS · FY25
$0.18
Dividend / sh · FY25
Payout · FY25
99%
ROE · FY25
3.9%
Net margin · FY25
3.2%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 7.2B
Revenue, FY2025 · full 11-year series below
Revenue Net income
48127.20.220152018202120242025
48127.20.22016201920222025

3 cents of every revenue dollar became profit this year.

Per share
USD 0.18
Diluted EPS, FY2025
EPS
0.81.62.40.1820152018202120242025
0.81.62.40.182016201920222025

The company pays no cash dividend.

Profitability
3.9%
Return on equity, FY2025
ROE
2040603.9%20152018202120242025
2040603.9%2016201920222025
Operating margin8.1%
Net margin3.2%
Return on assets1.9%

Each USD of equity produced 4 cents of profit this year.

Returned to shareholders
USD 224.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 224.0M
Net buybacks
Share of profit99.1%
Consecutive raises

USD 224.0M in dividends — 99% of the year's profit went back to shareholders.

Growth
+7.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.6%
+7.2%
+2.8%
Net income
−52.9%
+83.0%
−7.8%
EPS, diluted
−52.4%
+78.3%
−7.7%
Returned to shareholders
−42.3%
+13.7%
−4.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
Shares outstanding, FY2025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 12.4B
total assets, end of FY2025
Total assetsUSD 12.4B
EquityUSD 6.0B
CashUSD 291.0M
Current ratio1.33×

Equity funds 48% of total assets.

History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
7.2
6.8
7.5
10.0
7.0
5.0
5.3
5.6
5.4
5.4
5.4
Operating income $B
0.6
0.8
1.1
3.5
1.2
0.2
0.8
1.5
0.6
−0.0
0.8
EBITDA $B
1.3
1.4
1.7
4.0
1.7
0.8
1.2
1.9
1.0
0.4
1.2
Income tax $B
0.2
0.2
0.3
1.2
0.3
0.0
0.1
0.1
0.2
0.1
0.2
Net income $B
0.2
0.4
0.6
2.2
0.8
0.0
0.5
1.2
0.4
−0.1
0.5
EPS, diluted $
0.18
0.32
0.50
1.67
0.60
0.01
0.37
0.97
0.29
−0.10
0.40
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
99
62
73
54
35
1073
57
19
65
−133
68
ROE %
3.9
7.1
11.5
43.2
18.5
0.3
12.3
37.3
13.4
−4.7
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
42 of 42
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed